Classification
Compound class	Synthetic organic
Approved drug?	Yes (source: FDA (2003), EMA (2009))

IUPAC Name

N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine

International Nonproprietary Names
INN number	INN
8204	gefitinib

Synonyms

Iressa®

ZD 1839

ZD1839

Database Links
CAS Registry No.	184475-35-2
ChEBI	CHEBI:49668
ChEMBL Ligand	CHEMBL939
DrugBank Ligand	DB00317
PubChem CID	123631
RCSB PDB Ligand	IRE
Search Google for chemical match using the InChIKey	XGALLCVXEZPNRQ-UHFFFAOYSA-N
Search Google for chemicals with the same backbone	XGALLCVXEZPNRQ
Search PubMed clinical trials	gefitinib
Search PubMed titles	gefitinib
Search PubMed titles/abstracts	gefitinib
Wikipedia	Gefitinib

Comments

Gefitinib is an orally active Type-1 kinase inhibitor and was first approved by the US FDA in 2003. Gefitinib has selectivity for the EGFR [4].